NCT05972798View on ClinicalTrials.gov

Exploration of the Potential Mechanisms of n-3 Fatty Acids Supplementation in Depression and Cognitive Function in Patients With Late-life Depression

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

September 25, 2018

Study Completion Date

December 25, 2020

Conditions
Late Life Depression
Interventions
OTHER

Omega-3 fatty acids

2.2 g/d omega-3 PUFAs (1.2g EPA and 1g DHA per day) in patients with LLD

OTHER

Soybean oil

Soybean oil in patients with LLD

Trial Locations (1)

Unknown

Che-min Lin, Keelung

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT05972798 - Exploration of the Potential Mechanisms of n-3 Fatty Acids Supplementation in Depression and Cognitive Function in Patients With Late-life Depression | Biotech Hunter | Biotech Hunter